مصطلحات الفهرس: prednisolone, antiviral therapy, article, aspiration pneumonia/dt [Drug Therapy], blood sampling, brain death, bronchoalveolar lavage fluid, case report, clinical article, diabetic nephropathy/su [Surgery], diabetic nephropathy/th [Therapy], disease course, drug substitution, drug withdrawal, female, follow up, graft recipient, heart arrest/co [Complication], hepatitis, herpes simplex/co [Complication], herpes simplex/di [Diagnosis], herpes simplex/dt [Drug Therapy], Herpes simplex virus 2, human, Human alphaherpesvirus 1, human tissue, immunosuppressive treatment, insulin dependent diabetes mellitus/su [Surgery], insulin dependent diabetes mellitus/th [Therapy], kidney biopsy, kidney pancreas transplantation, laboratory test, laparotomy, liver graft, male, medical record, middle aged, nonhuman, nucleotide sequence, organ donor, organ transplantation, peritoneal dialysis, postoperative complication/co [Complication], priority journal, reinfection, resuscitation, sequence homology, skin infection, treatment duration, viremia, virus transmission, aciclovir/dt [Drug Therapy], aciclovir/iv [Intravenous Drug Administration], aspartate aminotransferase/ec [Endogenous Compound], ciprofloxacin/dt [Drug Therapy], fluconazole/dt [Drug Therapy], gamma glutamyltransferase/ec [Endogenous Compound], ganciclovir/dt [Drug Therapy], immunoglobulin G/ec [Endogenous Compound], immunoglobulin M/ec [Endogenous Compound], piperacillin plus tazobactam/dt [Drug Therapy], valaciclovir/dt [Drug Therapy], valaciclovir/po [Oral Drug Administration], valganciclovir/dt [Drug Therapy], vancomycin/dt [Drug Therapy], acute heart infarction/co [Complication], adult, aged, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38606Test
Transplant Infectious Disease
Click here for full text options
LibKey Link

مصطلحات الفهرس: prednisolone, antiviral therapy, article, aspiration pneumonia/dt [Drug Therapy], blood sampling, brain death, bronchoalveolar lavage fluid, case report, clinical article, diabetic nephropathy/su [Surgery], diabetic nephropathy/th [Therapy], disease course, drug substitution, drug withdrawal, female, follow up, graft recipient, heart arrest/co [Complication], hepatitis, herpes simplex/co [Complication], herpes simplex/di [Diagnosis], herpes simplex/dt [Drug Therapy], Herpes simplex virus 2, human, Human alphaherpesvirus 1, human tissue, immunosuppressive treatment, insulin dependent diabetes mellitus/su [Surgery], insulin dependent diabetes mellitus/th [Therapy], kidney biopsy, kidney pancreas transplantation, laboratory test, laparotomy, liver graft, male, medical record, middle aged, nonhuman, nucleotide sequence, organ donor, organ transplantation, peritoneal dialysis, postoperative complication/co [Complication], priority journal, reinfection, resuscitation, sequence homology, skin infection, treatment duration, viremia, virus transmission, aciclovir/dt [Drug Therapy], aciclovir/iv [Intravenous Drug Administration], aspartate aminotransferase/ec [Endogenous Compound], ciprofloxacin/dt [Drug Therapy], fluconazole/dt [Drug Therapy], gamma glutamyltransferase/ec [Endogenous Compound], ganciclovir/dt [Drug Therapy], immunoglobulin G/ec [Endogenous Compound], immunoglobulin M/ec [Endogenous Compound], piperacillin plus tazobactam/dt [Drug Therapy], valaciclovir/dt [Drug Therapy], valaciclovir/po [Oral Drug Administration], valganciclovir/dt [Drug Therapy], vancomycin/dt [Drug Therapy], acute heart infarction/co [Complication], adult, aged, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38606Test
Transplant Infectious Disease
Click here for full text options
LibKey Link

مصطلحات الفهرس: diabetic nephropathy/di [Diagnosis], diabetic nephropathy/dt [Drug Therapy], diabetic nephropathy/ep [Epidemiology], diabetic nephropathy/et [Etiology], diabetic nephropathy/su [Surgery], diabetic nephropathy/th [Therapy], diet therapy, disease surveillance, drug effect, drug targeting, glycemic control, human, inflammation, intracellular signaling, kidney biopsy, kidney blood flow, kidney metabolism, kidney pancreas transplantation, lifestyle modification, medical history, molecular pathology, nonhuman, oxidative stress, risk factor, risk reduction, screening test, tea, treatment planning, aldose reductase inhibitor/dt [Drug Therapy], aldosterone antagonist/cb [Drug Combination], aldosterone antagonist/dt [Drug Therapy], aliskiren/dt [Drug Therapy], aminoguanidine/dt [Drug Therapy], angiotensin receptor antagonist/cb [Drug Combination], angiotensin receptor antagonist/dt [Drug Therapy], atrasentan/dt [Drug Therapy], avosentan/dt [Drug Therapy], bardoxolone/dt [Drug Therapy], neutrophil gelatinase associated lipocalin/ec [Endogenous Compound], palosuran/dt [Drug Therapy], phosphodiesterase inhibitor/dt [Drug Therapy], pirfenidone/dt [Drug Therapy], pyridoxamine/dt [Drug Therapy], renin inhibitor/cb [Drug Combination], renin inhibitor/dt [Drug Therapy], sulodexide/dt [Drug Therapy], transforming growth factor beta1/ec [Endogenous Compound], unclassified drug, unindexed drug, vitamin D/dt [Drug Therapy], zinc, protein L FABP/ec [Endogenous Compound], vasculotropin/ec [Endogenous Compound], biological marker/ec [Endogenous Compound], calcium channel blocking agent/cb [Drug Combination], calcium channel blocking agent/dt [Drug Therapy], connective tissue growth factor/ec [Endogenous Compound], cystatin C/ec [Endogenous Compound], cytokine/ec [Endogenous Compound], dipeptidyl carboxypeptidase inhibitor/cb [Drug Combination], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], fish oil, hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], kidney injury molecule 1/ec [Endogenous Compound], alternative medicine, article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41642Test
International Journal of Nephrology and Renovascular Disease
Click here for full text options
LibKey Link

مصطلحات الفهرس: diabetic nephropathy/di [Diagnosis], diabetic nephropathy/dt [Drug Therapy], diabetic nephropathy/ep [Epidemiology], diabetic nephropathy/et [Etiology], diabetic nephropathy/su [Surgery], diabetic nephropathy/th [Therapy], diet therapy, disease surveillance, drug effect, drug targeting, glycemic control, human, inflammation, intracellular signaling, kidney biopsy, kidney blood flow, kidney metabolism, kidney pancreas transplantation, lifestyle modification, medical history, molecular pathology, nonhuman, oxidative stress, risk factor, risk reduction, screening test, tea, treatment planning, aldose reductase inhibitor/dt [Drug Therapy], aldosterone antagonist/cb [Drug Combination], aldosterone antagonist/dt [Drug Therapy], aliskiren/dt [Drug Therapy], aminoguanidine/dt [Drug Therapy], angiotensin receptor antagonist/cb [Drug Combination], angiotensin receptor antagonist/dt [Drug Therapy], atrasentan/dt [Drug Therapy], avosentan/dt [Drug Therapy], bardoxolone/dt [Drug Therapy], neutrophil gelatinase associated lipocalin/ec [Endogenous Compound], palosuran/dt [Drug Therapy], phosphodiesterase inhibitor/dt [Drug Therapy], pirfenidone/dt [Drug Therapy], pyridoxamine/dt [Drug Therapy], renin inhibitor/cb [Drug Combination], renin inhibitor/dt [Drug Therapy], sulodexide/dt [Drug Therapy], transforming growth factor beta1/ec [Endogenous Compound], unclassified drug, unindexed drug, vitamin D/dt [Drug Therapy], zinc, protein L FABP/ec [Endogenous Compound], vasculotropin/ec [Endogenous Compound], biological marker/ec [Endogenous Compound], calcium channel blocking agent/cb [Drug Combination], calcium channel blocking agent/dt [Drug Therapy], connective tissue growth factor/ec [Endogenous Compound], cystatin C/ec [Endogenous Compound], cytokine/ec [Endogenous Compound], dipeptidyl carboxypeptidase inhibitor/cb [Drug Combination], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], fish oil, hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], kidney injury molecule 1/ec [Endogenous Compound], alternative medicine, article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41642Test
International Journal of Nephrology and Renovascular Disease
Click here for full text options
LibKey Link

مصطلحات الفهرس: article, Australia, comorbidity, diabetes mellitus, diabetic nephropathy/co [Complication], diabetic nephropathy/ep [Epidemiology], diabetic nephropathy/su [Surgery], diabetic nephropathy/th [Therapy], female, hemodialysis, human, kidney failure/ep [Epidemiology], kidney failure/su [Surgery], kidney transplantation, major clinical study, male, mortality, non insulin dependent diabetes mellitus, peritoneal dialysis, priority journal, renal replacement therapy, survival rate, kidney failure/th [Therapy], adult, aged, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31236Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: article, Australia, comorbidity, diabetes mellitus, diabetic nephropathy/co [Complication], diabetic nephropathy/ep [Epidemiology], diabetic nephropathy/su [Surgery], diabetic nephropathy/th [Therapy], female, hemodialysis, human, kidney failure/ep [Epidemiology], kidney failure/su [Surgery], kidney transplantation, major clinical study, male, mortality, non insulin dependent diabetes mellitus, peritoneal dialysis, priority journal, renal replacement therapy, survival rate, kidney failure/th [Therapy], adult, aged, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31236Test
LibKey Link

مصطلحات الفهرس: simvastatin/dt [Drug Therapy], triacylglycerol/ec [Endogenous Compound], vitamin D, dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], diuretic agent/dt [Drug Therapy], ezetimibe plus simvastatin/ae [Adverse Drug Reaction], ezetimibe plus simvastatin/ct [Clinical Trial], ezetimibe plus simvastatin/cm [Drug Comparison], ezetimibe plus simvastatin/dt [Drug Therapy], high density lipoprotein cholesterol/ec [Endogenous Compound], low density lipoprotein cholesterol/ec [Endogenous Compound], phosphate binding agent/dt [Drug Therapy], placebo, recombinant erythropoietin, simvastatin/ae [Adverse Drug Reaction], simvastatin/cm [Drug Comparison], aspartate aminotransferase blood level, atherosclerosis, biliary tract disease/si [Side Effect], brain ischemia, cause of death, cholesterol blood level, chronic kidney disease/dt [Drug Therapy], chronic kidney disease/th [Therapy], chronic pancreatitis/si [Side Effect], clinical trial, controlled clinical trial, controlled study, creatinine blood level, creatinine urine level, diabetes mellitus, diabetic nephropathy/dt [Drug Therapy], diabetic nephropathy/th [Therapy], drug effect, drug efficacy, drug safety, female, follow up, gallstone/si [Side Effect], glomerulonephritis/dt [Drug Therapy], glomerulonephritis/th [Therapy], heart death, heart infarction, hemodialysis, hepatitis/si [Side Effect], human, hypertension/dt [Drug Therapy], hypertension/th [Therapy], kidney polycystic disease/dt [Drug Therapy], kidney polycystic disease/th [Therapy], lipoprotein blood level, liver toxicity/si [Side Effect], maintenance therapy, major clinical study, male, microalbuminuria, myalgia/si [Side Effect], myopathy/si [Side Effect], obstructive uropathy/dt [Drug Therapy], obstructive uropathy/th [Therapy], outcome assessment, peritoneal dialysis, priority journal, protein urine level, pyelonephritis/dt [Drug Therapy], pyelonephritis/th [Therapy], randomized controlled trial, renovascular disease/dt [Drug Therapy], renovascular disease/th [Therapy], revascularization, rhabdomyolysis/si [Side Effect], side effect/si [Side Effect], triacylglycerol blood level, vascular disease, acetylsalicylic acid, albumin/ec [Endogenous Compound], angiotensin receptor antagonist/dt [Drug Therapy], anticoagulant agent/po [Oral Drug Administration], antithrombocytic agent, apolipoprotein A1/ec [Endogenous Compound], apolipoprotein B/ec [Endogenous Compound], beta adrenergic receptor blocking agent/dt [Drug Therapy], calcium channel blocking agent/dt [Drug Therapy], creatinine/ec [Endogenous Compound], acute pancreatitis/si [Side Effect], adult, aged, alanine aminotransferase blood level, article, Article

URL: American Heart Journal
Click here for full text options
LibKey Link

مصطلحات الفهرس: simvastatin/dt [Drug Therapy], triacylglycerol/ec [Endogenous Compound], vitamin D, dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], diuretic agent/dt [Drug Therapy], ezetimibe plus simvastatin/ae [Adverse Drug Reaction], ezetimibe plus simvastatin/ct [Clinical Trial], ezetimibe plus simvastatin/cm [Drug Comparison], ezetimibe plus simvastatin/dt [Drug Therapy], high density lipoprotein cholesterol/ec [Endogenous Compound], low density lipoprotein cholesterol/ec [Endogenous Compound], phosphate binding agent/dt [Drug Therapy], placebo, recombinant erythropoietin, simvastatin/ae [Adverse Drug Reaction], simvastatin/cm [Drug Comparison], aspartate aminotransferase blood level, atherosclerosis, biliary tract disease/si [Side Effect], brain ischemia, cause of death, cholesterol blood level, chronic kidney disease/dt [Drug Therapy], chronic kidney disease/th [Therapy], chronic pancreatitis/si [Side Effect], clinical trial, controlled clinical trial, controlled study, creatinine blood level, creatinine urine level, diabetes mellitus, diabetic nephropathy/dt [Drug Therapy], diabetic nephropathy/th [Therapy], drug effect, drug efficacy, drug safety, female, follow up, gallstone/si [Side Effect], glomerulonephritis/dt [Drug Therapy], glomerulonephritis/th [Therapy], heart death, heart infarction, hemodialysis, hepatitis/si [Side Effect], human, hypertension/dt [Drug Therapy], hypertension/th [Therapy], kidney polycystic disease/dt [Drug Therapy], kidney polycystic disease/th [Therapy], lipoprotein blood level, liver toxicity/si [Side Effect], maintenance therapy, major clinical study, male, microalbuminuria, myalgia/si [Side Effect], myopathy/si [Side Effect], obstructive uropathy/dt [Drug Therapy], obstructive uropathy/th [Therapy], outcome assessment, peritoneal dialysis, priority journal, protein urine level, pyelonephritis/dt [Drug Therapy], pyelonephritis/th [Therapy], randomized controlled trial, renovascular disease/dt [Drug Therapy], renovascular disease/th [Therapy], revascularization, rhabdomyolysis/si [Side Effect], side effect/si [Side Effect], triacylglycerol blood level, vascular disease, acetylsalicylic acid, albumin/ec [Endogenous Compound], angiotensin receptor antagonist/dt [Drug Therapy], anticoagulant agent/po [Oral Drug Administration], antithrombocytic agent, apolipoprotein A1/ec [Endogenous Compound], apolipoprotein B/ec [Endogenous Compound], beta adrenergic receptor blocking agent/dt [Drug Therapy], calcium channel blocking agent/dt [Drug Therapy], creatinine/ec [Endogenous Compound], acute pancreatitis/si [Side Effect], adult, aged, alanine aminotransferase blood level, article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26987Test
American Heart Journal
LibKey Link